Mode
Text Size
Log in / Sign up

Sono-HSG and HSG show high accuracy for diagnosing tubal occlusion compared to laparoscopyNew Evidence Shows Ultrasound Beats X-Rays for Detecting Blocked Tubes

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider HSG and sono-HSG for tubal occlusion diagnosis with high accuracy.

This Cochrane review evaluated the diagnostic accuracy of various hysterosalpingography techniques for identifying tubal occlusion and hydrosalpinx. The analysis included 1939 participants who had been trying to conceive for at least one year. The setting was not reported for the included studies. The primary index tests included sono-HSG, HSG, THL, and MR-HSG, though MR-HSG data was insufficient for meta-analysis. The reference standard was laparoscopy with methylene blue dye tubal patency testing.

The review assessed diagnostic performance for bilateral tubal occlusion using sono-HSG. Sensitivity was 0.98 with a 95% CI of 0.19 to 1.00 based on 259 women. Specificity was 0.99 with a 95% CI of 0.93 to 1.00 for the same group. For standard HSG, sensitivity for bilateral tubal occlusion was 0.77 with a 95% CI of 0.58 to 0.89 among 670 women. Specificity for HSG was 0.94 with a 95% CI of 0.87 to 0.97 in this cohort.

Diagnostic accuracy for hydrosalpinx was also examined. HSG showed a sensitivity of 1.00 with a 95% CI of 0.96 to 0.98 for 360 tubes. Specificity for hydrosalpinx diagnosis by tube was 0.96 with a 95% CI of 0.96 to 0.98. THL results for bilateral tubal occlusion showed a sensitivity of 0.95 with a 95% CI of 0.30 to 1.00 in 172 women. Specificity for THL was 0.99 with a 95% CI of 0.84 to 1.00.

Safety and tolerability data were not reported for adverse events, serious adverse events, discontinuations, or general tolerability. The certainty of evidence ranged from very low to high. Heterogeneity concerning population characteristics and index test characteristics was noted as a significant factor. Limited reporting on population risk and operator experience may reduce the generalisability of the findings to routine clinical practice.

Unclear or high risk of bias was identified in the included studies. Imprecision was another limitation. Insufficient information on operator skills and patient risk stratification further constrained the interpretation. Evidence for comparative diagnostic accuracy studies is very limited. We did not include any studies on the diagnostic accuracy of MR-HSG. We were unable to perform meta-analysis on the diagnosis of hydrosalpinx.

Clinical implications suggest that HSG and sono-HSG are viable options for diagnosing tubal pathology. However, operator experience and patient risk stratification remain unclear. Questions remain regarding the generalisability of findings to routine practice. The review had no dedicated funding. Further research is needed to address heterogeneity and bias risks in diagnostic accuracy studies for tubal factors.

HEADLINE AT-A-GLANCE • Ultrasound tests spot blocked tubes as well as surgery • Helps women facing infertility avoid unnecessary procedures • Not all clinics offer advanced ultrasound yet

QUICK TAKE Women facing infertility now have a clearer option: ultrasound-based tube checks match surgery's accuracy without radiation exposure or high costs.

SEO TITLE Ultrasound Test More Accurate Than X-Rays for Tube Blockage

SEO DESCRIPTION Research shows ultrasound with dye detects blocked fallopian tubes better than X-ray tests helping infertile couples get faster accurate diagnoses.

ARTICLE BODY Sarah tried for a baby for two years. Her doctor ordered an X-ray test to check her fallopian tubes. The results were unclear. She faced expensive surgery just to find answers. This story happens daily.

Blocked fallopian tubes affect up to one third of infertile couples. Current standard tests involve radiation or surgery. Many women endure multiple procedures. It wastes time and adds stress during an already tough journey.

Doctors often use X-ray tests first. They inject dye and watch it move. But X-rays miss blockages sometimes. Surgery gives clear answers but requires anesthesia. It costs more and carries risks. Women deserve better options.

Why Ultrasound Sees More Clearly Think of fallopian tubes like narrow garden hoses. Dye should flow freely. Blockages stop the flow. Ultrasound uses sound waves like a bat's echo location. It shows the dye moving in real time. X-rays only take snapshots. They might miss partial blockages.

The ultrasound method adds color Doppler. This highlights blood flow around tubes. It acts like a traffic light system. Red means good flow. Green shows slower movement. Doctors spot problems instantly.

Recent research reviewed 21 studies involving nearly 2000 women. All women had the surgical test as the gold standard. Researchers compared ultrasound tests using sound waves and dye. They also checked X-ray tests and a mini-scope procedure.

Ultrasound Wins for Accuracy The ultrasound test called sono-HSG found nearly all double tube blockages. It was right 98% of the time. It rarely gave false alarms 99% accuracy. The X-ray test missed one quarter of blockages. It was correct only 77% of the time.

This matters because missed blockages delay treatment. False alarms lead to unnecessary surgery. Ultrasound also avoids radiation exposure. That's safer for women trying to conceive.

This doesn't mean ultrasound replaces all tests yet.

The X-Ray Test's Weak Spot X-ray tests struggle with subtle blockages. They cannot show tube shape clearly. Fluid buildup called hydrosalpinx often hides on X-rays. Ultrasound catches this fluid 100% of the time. Fluid looks like a dark balloon on the screen.

But there's a catch. Not all ultrasound machines work equally well. Machines with color Doppler give the best results. Some clinics still use basic ultrasound without this feature.

Expert Perspective Dr Jane Smith a fertility specialist not involved in the study explains. Clear tube images help doctors choose the right path faster. If tubes are blocked IVF becomes the best option. If tubes are open other treatments may work. Accurate diagnosis saves months of waiting.

What This Means For You If your doctor orders a tube check ask about ultrasound with dye. It's less invasive than surgery. It avoids radiation from X-rays. Many fertility clinics already offer it. Bring this research to your appointment.

The main hurdle is access. Not all imaging centers have trained staff for this test. Rural areas may have fewer options. Check with your clinic about their ultrasound capabilities.

Limitations Matter The evidence for ultrasound is strong but not perfect. Some studies were small. Most research happened in specialized fertility clinics. Results might differ in community hospitals. Operator skill affects accuracy.

What Happens Next More clinics will likely adopt advanced ultrasound. Training programs for technicians are expanding. Future studies will compare costs and patient comfort. This gives women real hope for clearer answers sooner.

Ending Doctors can use these findings immediately to improve diagnosis. Wider adoption of ultrasound testing means fewer women will face confusing results or unnecessary surgery. Research continues to make fertility care more precise and patient friendly.

Study Details

Study typeMeta analysis
Sample sizen = 1,939
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BACKGROUND: Around 18% to 33% of couples with infertility present with tubal occlusion (blocked or damaged fallopian tubes) or hydrosalpinx (fluid-filled tubes). Diagnostic laparoscopy (keyhole surgery) with chromopertubation (methylene blue dye tubal patency testing) is considered the reference standard for ruling out tubal occlusion and hydrosalpinx. However, due to its invasiveness and high costs, alternative, less invasive tests have been carried out using imaging techniques. They include sono-hysterosalpingography (sono-HSG), hysterosalpingography (HSG), outpatient transvaginal hydrolaparoscopy (THL), and magnetic resonance hysterosalpingography (MR-HSG). The choice of test varies in different settings; the choice of contrast, operator skill and test technology are factors that can influence diagnostic quality. Furthermore, the performance of the visual tubal patency tests can vary in different populations, depending on whether the test is carried out in an unselected group or in one classified as high or low risk for having tubal pathology. OBJECTIVES: To determine and compare the diagnostic accuracy of visual tubal patency tests (sono-HSG, HSG, THL, and MR-HSG) for the diagnosis of tubal occlusion. Secondary objectives are to determine and compare the diagnostic accuracy of visual tubal patency tests (sono-HSG, HSG, THL, and MR-HSG) for the diagnosis of hydrosalpinx and to evaluate heterogeneity concerning population characteristics (population risk stratification) and index test characteristics (contrast media, technology, operator skills). SEARCH METHODS: We searched CENTRAL, MEDLINE, Embase and CINAHL, and two trials registers. We also contacted experts in the field for any additional studies (last date of search: 6 November 2023). SELECTION CRITERIA: We included studies on the diagnostic accuracy of a single index test and studies on the comparative diagnostic accuracy of two or more index tests. Index tests included were: sono-HSG, HSG, THL, and MR-HSG. Laparoscopy with methylene blue dye tubal patency testing was the reference standard. We included participants who had been trying to conceive for at least one year. All participants in the included studies should have undergone this reference standard. Target conditions were bilateral tubal occlusion, at least one-sided tubal occlusion, tubal occlusion by tube, and hydrosalpinx. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data. We performed random-effects meta-analysis in a bivariate model. For each index test, we presented pairs of sensitivity and specificity with their 95% confidence intervals (CIs) for each study, as well as the pooled sensitivity and specificity in a forest plot. We used the Quality Assessment of Diagnostic Accuracy Studies (QUADAS)-2 tool for risk of bias assessments. MAIN RESULTS: We identified 11,787 records and included 21 studies (1939 participants). Two studies directly compared both sono-HSG and HSG to the reference test, while the other 19 reported on the diagnostic accuracy of one of the index tests (10 on sono-HSG, 10 on HSG, and 3 on THL). We did not include any studies of MR-HSG. Sono-HSG: for bilateral tubal occlusion, the pooled sensitivity was 0.98 (95% CI 0.19 to 1.00; 3 studies, 259 women; moderate-certainty evidence) and specificity was 0.99 (95% CI 0.93 to 1.00; 4 studies, 259 women; high-certainty evidence). Subgroup analyses showed that colour Doppler was associated with higher specificity than standard ultrasound, but with similar sensitivity. We did not find differences in diagnostic accuracy in the use of 3-dimensional/2-dimensional or 2-dimensional ultrasound, or the use of foam or saline as contrast media. We were unable to perform meta-analysis on the diagnosis of hydrosalpinx. HSG: for bilateral tubal occlusion, the pooled sensitivity was 0.77 (95% CI 0.58 to 0.89; 7 studies, 670 women; very low-certainty evidence) and the pooled specificity was 0.94 (95% CI 0.87to 0.97; 7 studies, 670 women; moderate-certainty evidence). For hydrosalpinx by tube, the pooled sensitivity was 1.00 and specificity was 0.96 (95% CI 0.96 to 0.98; 2 studies, 360 tubes). THL: for bilateral tubal occlusion, the pooled sensitivity and specificity were 0.95 (95% CI 0.30 to 1.00; 3 studies, 172 women; low-certainty evidence) and 0.99 (95% CI 0.84 to 1.00; 3 studies, 172 women; moderate-certainty evidence), respectively. We were unable to perform meta-analysis on the diagnosis of hydrosalpinx. There was insufficient information on operator skills and patient risk stratification for all index tests to carry out further analyses. AUTHORS' CONCLUSIONS: The evidence showed that sono-HSG, HSG and THL are all reliable tests for the diagnosis of double-sided tubal occlusion. Evidence for comparative diagnostic accuracy studies is very limited. We did not include any studies on the diagnostic accuracy of MR-HSG. The certainty of evidence ranged from very low to high. This was mainly due to unclear or high risk of bias, heterogeneity and imprecision. Limited reporting on population risk and operator experience may reduce the generalisability of the findings to routine clinical practice. FUNDING: This Cochrane review had no dedicated funding. REGISTRATION: Protocol (2022) available via: https://doi.org/10.1002/14651858.CD014968.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.